Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2019 1
2020 5
2021 10
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Effet d’un traitement par hydroxychloroquine prescrit comme traitement de fond de rhumatismes inflammatoires chroniques ou maladies auto-immunes systémiques sur les tests diagnostiques et l’évolution de l’infection à SARS CoV-2: étude de 871 patients.
Trefond L, Drumez E, Andre M, Costedoat-Chalumeau N, Seror R, Devaux M, Dernis E, Dieudonne Y, Mahou SE, Lanteri A, Melki I, Queyrel V, Roumier M, Schmidt J, Barnetche T, Thomas T, Cacoub P, Belot A, Aumaitre O, Richez C, Hachulla E; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium et contributeurs. Trefond L, et al. Among authors: roumier m. Rev Rhum Ed Fr. 2021 Sep 29. doi: 10.1016/j.rhum.2021.09.004. Online ahead of print. Rev Rhum Ed Fr. 2021. PMID: 34602813 Free PMC article. French. No abstract available.
IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes.
Moussiegt A, Müller R, Ebbo M, Grados A, Graveleau J, Ackermann F, Bachmeyer C, Bernit E, Blanche P, Canoui E, Chaix F, Costedoat-Chalumeau N, Groote P, Etienne N, Fior R, Flamarion E, Kennel T, Launay D, Lerolle N, Limal N, Loustau V, Menage E, Moulis G, Papo T, Pouchot J, Quemeneur T, Roumier M, Tchérakian C, Lefèvre G, Rebours V, Kahn JE, Schleinitz N, Groh M; CEREO; French IgG4-RD Study Group. Moussiegt A, et al. Among authors: roumier m. Autoimmun Rev. 2021 Sep;20(9):102889. doi: 10.1016/j.autrev.2021.102889. Epub 2021 Jul 5. Autoimmun Rev. 2021. PMID: 34237420 No abstract available.
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.
Roumier M, Paule R, Vallée A, Rohmer J, Ballester M, Brun AL, Cerf C, Chabi ML, Chinet T, Colombier MA, Farfour E, Fourn E, Géri G, Khau D, Marroun I, Ponsoye M, Roux A, Salvator H, Schoindre Y, Si Larbi AG, Tchérakian C, Vasse M, Verrat A, Zuber B, Couderc LJ, Kahn JE, Groh M, Ackermann F; Foch COVID-19 Study Group. Roumier M, et al. J Clin Immunol. 2021 Feb;41(2):303-314. doi: 10.1007/s10875-020-00911-6. Epub 2020 Nov 14. J Clin Immunol. 2021. PMID: 33188624 Free PMC article.
High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia.
Roumier M, Le Burel S, Audia S, Chauchet A, Gousseff M, Hamidou M, Liferman F, Moulis G, Lioger B, Galicier L, Ebbo M, London J, Poutrel S, Terriou L, Zarrouk V, Michel M, Godeau B, Mahevas M. Roumier M, et al. Am J Hematol. 2021 Feb 1;96(2):E43-E46. doi: 10.1002/ajh.26040. Epub 2020 Nov 23. Am J Hematol. 2021. PMID: 33125750 No abstract available.
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
Danlos FX, Grajeda-Iglesias C, Durand S, Sauvat A, Roumier M, Cantin D, Colomba E, Rohmer J, Pommeret F, Baciarello G, Willekens C, Vasse M, Griscelli F, Fahrner JE, Goubet AG, Dubuisson A, Derosa L, Nirmalathasan N, Bredel D, Mouraud S, Pradon C, Stoclin A, Rozenberg F, Duchemin J, Jourdi G, Ellouze S, Levavasseur F, Albigès L, Soria JC, Barlesi F, Solary E, André F, Pène F, Ackerman F, Mouthon L, Zitvogel L, Marabelle A, Michot JM, Fontenay M, Kroemer G. Danlos FX, et al. Among authors: roumier m. Cell Death Dis. 2021 Mar 11;12(3):258. doi: 10.1038/s41419-021-03540-y. Cell Death Dis. 2021. PMID: 33707411 Free PMC article. Clinical Trial.
High levels of TNFα in patients with COVID-19 refractory to tocilizumab.
Danlos FX, Ackermann F, Rohmer J, Roumier M, Marabelle A, Michot JM. Danlos FX, et al. Among authors: roumier m. Eur J Cancer. 2021 May;149:102-104. doi: 10.1016/j.ejca.2021.01.056. Epub 2021 Mar 20. Eur J Cancer. 2021. PMID: 33848711 Free PMC article. No abstract available.
CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.
Bernard-Valnet R, Moisset X, Maubeuge N, Lefebvre M, Ouallet JC, Roumier M, Lebrun-Frenay C, Ciron J, Biotti D, Clavelou P, Godeau B, Du Pasquier RA, Martin-Blondel G. Bernard-Valnet R, et al. Among authors: roumier m. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 2;9(1):e1097. doi: 10.1212/NXI.0000000000001097. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34728496 Free PMC article.
A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity.
Vasse M, Zuber B, Goubeau L, Ballester MC, Roumier M, Delcominette F, Habarou F, Jolly E, Ackermann F, Cerf C, Farfour E, Pascreau T; SARS-CoV-2 Foch Hospital Study Group. Vasse M, et al. Among authors: roumier m. Clin Chem Lab Med. 2021 Feb 22;59(7):1315-1322. doi: 10.1515/cclm-2020-1801. Print 2021 Jun 25. Clin Chem Lab Med. 2021. PMID: 33606928
Assessment of T-cell polarization on the basis of surface marker expression: Diagnosis and potential therapeutic implications in lymphocytic variant hypereosinophilic syndrome.
Ledoult E, Groh M, Kahn JE, Trauet J, Bouaziz JD, Caristan A, Cottin V, Dubucquoi S, Etienne N, Golden C, Guillaume-Jugnot P, Hachulla É, Launay D, Machelart I, De Masson A, Molinet T, Morati-Hafsaoui C, Puget M, Roumier M, Terriou L, Meresse B, Dendooven A, Copin MC, Dubois R, Labalette M, Lefèvre G; CEREO—French National Reference Center for Hypereosinophilic Syndromes. Ledoult E, et al. Among authors: roumier m. J Allergy Clin Immunol Pract. 2020 Mar;8(3):1110-1114.e2. doi: 10.1016/j.jaip.2019.08.049. Epub 2019 Sep 13. J Allergy Clin Immunol Pract. 2020. PMID: 31525539 No abstract available.
16 results